Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

D Moris, M Palta, C Kim, PJ Allen… - CA: a cancer journal …, 2023 - Wiley Online Library
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and
remains a fatal malignancy in the majority of patients. Approximately 20%–30% of patients …

Cholangiocarcinoma: current knowledge and new developments

B Blechacz - Gut and liver, 2016 - pmc.ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is
more common in Asia, its incidence in Europe and North America has significantly increased …

Liver resection and surgical strategies for management of primary liver cancer

ST Orcutt, DA Anaya - Cancer control, 2018 - journals.sagepub.com
Primary liver cancer—including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC)—incidence is increasing and is an important source of cancer …

Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis

MN Mavros, KP Economopoulos, VG Alexiou… - JAMA …, 2014 - jamanetwork.com
Importance Data on outcomes following surgical management of intrahepatic
cholangiocarcinoma (ICC) are limited. The incidence of ICC is increasing and it has a poor …

[HTML][HTML] Intrahepatic cholangiocarcinoma: expert consensus statement

SM Weber, D Ribero, EM O'Reilly, N Kokudo… - Hpb, 2015 - Elsevier
Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …

Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management

H Zhang, T Yang, M Wu, F Shen - Cancer letters, 2016 - Elsevier
Intrahepatic cholangiocarcinoma (ICC), the least common form of cholangiocarcinomas, is a
rare hepatobiliary malignancy that arises from the epithelial cells of the intrahepatic bile …

Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma

A Lauterio, R De Carlis, L Centonze, V Buscemi… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

F Song, BO Hu, JW Cheng, YF Sun, KQ Zhou… - Cell death & …, 2020 - nature.com
Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor derived from bile duct
epithelium. Its characteristics include an insidious onset and frequent recurrence or …

Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma

JC Mejia, J Pasko - Surgical Clinics, 2020 - surgical.theclinics.com
Primary Liver Cancers - Surgical Clinics Skip to Main Content Advertisement Surgical Clinics
Log in Register Log in Subscribe Claim Skip menu theclinics.com theclinics.com External Link …

[HTML][HTML] Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

M Simbolo, M Fassan, A Ruzzenente, A Mafficini… - Oncotarget, 2014 - ncbi.nlm.nih.gov
One-hundred-fifty-three biliary cancers, including 70 intrahepatic cholangiocarcinomas
(ICC), 57 extrahepatic cholangiocarcinomas (ECC) and 26 gallbladder carcinomas (GBC) …